Residon

\n

Risperidone

\nDescription \nRisperidone has been demonstrated to be efficacious in improving hallucinatory behavior, paranoia, bizarre thought content and conceptual disorganization when administered over short term to patients of schizophrenia. During initiation of therapy, orthostatic hypotension can occur due to alpha-adrenergic receptor antagonism. \n \nIndications \nResidon (Risperidone) is indicated for the management of manifestations of psychotic disorders. \nAcute schizophrenia \nChronic schizophrenia \nAffective symptomatology of schizophrenia \nOther psychoses \n \nSupply \nResidon 1 mg: Each box contains 5x10's tablets in alu-alu blister pack. \nResidon 2 mg: Each box contains 5x10's tablets in alu-alu blister pack. \nResidon 4 mg: Each box contains 5x10's tablets in alu-alu blister pack.